Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
3.010
+0.070 (2.38%)
At close: Jun 26, 2026, 4:00 PM EDT
2.920
-0.090 (-2.99%)
After-hours: Jun 26, 2026, 7:48 PM EDT
Veru Inc. Employees
Veru Inc. had 20 employees as of September 30, 2025. The number of employees decreased by 190 or -90.48% compared to the previous year.
Employees
20
Change (1Y)
-190
Growth (1Y)
-90.48%
Revenue / Employee
n/a
Profits / Employee
-$697,651
Market Cap
48.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 118 |
| Mereo BioPharma Group | 39 |
| Lantern Pharma | 16 |
| CervoMed | 15 |
| Apollomics | 14 |
| Actuate Therapeutics | 12 |
| Eloxx Pharmaceuticals | 10 |
| Hyperion DeFi | 9 |
VERU News
- 23 days ago - Veru pact with Novo ‘significant event,’ says Canaccord - TheFly
- 23 days ago - Veru announces clinical supply agreement with Novo Nordisk - TheFly
- 6 weeks ago - Veru price target lowered to $24 from $25 at Oppenheimer - TheFly
- 6 weeks ago - Veru Inc. Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Veru Inc. Earnings release: Q2 2026 - Filings
- 6 weeks ago - Veru Inc. Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress - GlobeNewsWire
- 7 weeks ago - Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th - GlobeNewsWire